News

Three men and a woman standing

Future Health joins BioConvergence Cancer Alliance as founding member

Future Health Initiatives

The BioConvergence Cancer Alliance at MIT’s Koch Institute is expanding its global network with the addition of a founding member: Future Health – A Global Initiative by Abu Dhabi.The partnership will create new opportunities for collaboration across research, healthcare, and industry, advancing efforts in cancer prevention, earlier detection, and more effective treatments  

Filter by

Filter by Title/Description

Filter by Topic

Filter by Year

Matthew Vander Heiden named Editor-in-Chief of AACR’s Cancer Discovery

American Association for Cancer Research

Congratulations to KI Director Matthew Vander Heiden on his appointment as Editor-in-Chief of Cancer Discovery, the American Association for Cancer Research's flagship journal and one of the world's leading cancer research publications. In this leadership role, he will help shape the publication of impactful research spanning basic, translational, and clinical cancer science.

A dynaMIT summer of discovery

MIT News

This summer, the Koch Institute is partnering with MIT’s student-run dynaMIT program to bring hands-on cancer research experiences to local middle school students. Through lab tours, interactive experiments, and conversations with scientists, students will get an inside look at the exciting work happening at the Koch Institute.

The power of curiosity-driven science

Scientific American

In the Scientific American, Robert Langer reflects on the resilience and curiosity behind scientific discovery in the United States. While he notes rising challenges to research funding and attracting the best talent, he says he finds optimism in America's 250 year-old tradition of learning, discovering and inventing even through periods of adversity, such as world wars and depressions.Langer encourages early-career scientists to stay ambitious. Rather than pursuing research that is "incremental and secure," he recommends taking a risk on "something that might be a really big idea and could change the world."

“I’m just a big believer in the resilience of people. I look at the history of American innovation and education over the past 250 years, and it’s been spectacular. Plenty of times there’ve been setbacks. We’ve had world wars, you know, we’ve had depressions, and people keep persisting and keep learning. They keep discovering and they keep inventing. So that gives me a lot of cause for hope.”

A star is reborn

Endpoints News

Innoviva will revive Lyndra’s long-acting drug delivery platform by launching the subsidiary Nortiva Bio. Lyndra, a startup built from discoveries from the laboratories of Robert By 2025, Langer and Giovanni Traverso, had advanced through Phase 3 trials of its star-shaped oral delivery system, but the company wound down amid funding hurdles. After acquiring Lyndra last September, Nortiva Bio will relaunch the drug-delivery platform as LYNXwith a focus on contraception; however, the technology has the potential to administer a range of therapies. 

A strong first year for New Manufacturing

MIT News

MIT's Initiative for New Manufacturing (INM), co-directed by Christopher Love, marked its first anniversary with Manufacturing Week, a series of events exploring topics in AI, entrepreneurship, and workforce innovation. The week's strong turnout reflected growing enthusiasm for the initiative. “The response and participation level has been huge. MIT Manufacturing Week proved that the appetite for change — from students to chief executives — is real and urgent,” says Paula T. Hammond, dean of MIT’s School of Engineering and co-chair of INM’s Steering Committee.

MIT Koch Institute and the Research Institute, National Cancer Center Japan launch strategic collaboration

MIT Koch Institute

The MIT Koch Institute and the Research Institute, National Cancer Center Japan, a leading national research institute focused on advancing oncology through basic and translational research, have signed a Memorandum of Understanding. The collaboration will leverage both parties’ excellence in research to solve the most pressing problems in cancer and shape the future of convergence science in oncology, specifically in the areas of immune-oncology, basic and epidemiologic cancer research, as well as prevention, diagnosis, screening, treatment, cancer control, and survivorship.

Caution for keto diets

MIT News

The Yilmaz lab found that ketogenic diets can promote tumor formation in the small intestine — an effect driven by how intestinal stem cells burn dietary fat, not by the ketone bodies these diets produce. The study, published in Nature, also showed that the diet's protective effect against colon tumors is independent of ketone bodies, challenging the prevailing view. Together, the findings reveal that the same diet can have opposite effects in different tissues, underscoring the need for caution in generalizing the effect of any diet on cancer.This work was supported by the Bridge Project, the MIT Stem Cell Initiative and the Koch Institute Frontier Research Program through the Kathy and Curt Marble Cancer Research Fund. 

Hammond Lab alum Claire Underwood wins Fulbright award

MIT News

Claire Underwood, a senior studying chemical-biological engineering and former researcher in the Hammond Lab, has received a Fulbright award to conduct research at the University of Minho in Portugal. There, she will study high-throughput fabrication techniques for cell-embedded microtissues with applications in drug discovery before pursuing a PhD in chemical engineering.

Whitney Henry named 2026 Searle Scholar

MIT News

Congratulations to Koch Institute faculty member Whitney Henry, one of four MIT scientists named a 2026 Searle Scholar and among just 15 selected nationwide. Henry's lab investigates ferroptosis, an iron-dependent form of cell death, to target therapy-resistant cancer cells driving tumor relapse. The award provides $450,000 in flexible funding over three years to support her work.

Robert Langer wins 2026 Welch Award in Chemistry

The Welch Foundation

Robert Langer has been named the 2026 recipient of the Robert A. Welch Award in Chemistry, established to recognize chemical research that meaningfully benefits humankind and carrying a $500,000 prize. His pioneering work in controlled drug release and tissue engineering has transformed patient care worldwide, generating tens of companies, licensing to over 400 organizations globally, and inspiring hundreds of researchers who now lead their own labs.